Earlier, Covaxin was approved for children above 12, while SII's Covishield was approved for persons above 18. The new order states that Covaxin will also be administered only to persons above 18.
Georgieva said the steps taken by the Modi government on the monetary policy and the fiscal policy side is commendable. It is actually slightly above the average for emerging markets, she added.